Gemcitabine improves survival in patients with recurrent or metastatic nasopharyngeal carcinoma

অনুযায়ী Hong, Shaodong, Zhang, Li
প্রকাশিত Chin J Cancer (2016)

Development and External Validation of Nomograms for Predicting Survival in Nasopharyngeal Carcinoma Patients after Definitive Radiotherapy

অনুযায়ী Yang, Lin, Hong, Shaodong, Wang, Yan, Chen, Haiyang, Liang, Shaobo, Peng, Peijian, Chen, Yong
প্রকাশিত Sci Rep (2015)

Concomitant Genetic Alterations With Response to Treatment and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With EGFR-Mutant Advanced Non–Small Cell Lung...

অনুযায়ী Hong, Shaodong, Gao, Fangfang, Fu, Sha, Wang, Yan, Fang, Wenfeng, Huang, Yan, Zhang, Li
প্রকাশিত JAMA Oncol (2018)

First-line treatment for patients with advanced non-small cell lung carcinoma and high PD-L1 expression: pembrolizumab or pembrolizumab plus chemotherapy

অনুযায়ী Zhou, Yixin, Lin, Zuan, Zhang, Xuanye, Chen, Chen, Zhao, Hongyun, Hong, Shaodong, Zhang, Li
প্রকাশিত J Immunother Cancer (2019)

MDM2/4 amplification predicts poor response to immune checkpoint inhibitors: a pan-cancer analysis

অনুযায়ী Fang, Wenfeng, Zhou, Huaqiang, Shen, Jiayi, Li, Jianwen, Zhang, Yaxiong, Hong, Shaodong, Zhang, Li
প্রকাশিত ESMO Open (2020)

Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma by Targeting the Epidermal Growth Factor Receptor Combined with Gemcitabine Plus Platinum

অনুযায়ী Chen, Chen, Zhang, Xuanye, Zhou, Yixin, Fu, Sha, Lin, Zuan, Hong, Shaodong, Zhang, Li
প্রকাশিত Cancer Manag Res (2020)

Low Prognostic Nutritional Index (PNI) Predicts Unfavorable Distant Metastasis-Free Survival in Nasopharyngeal Carcinoma: A Propensity Score-Matched Analysis

অনুযায়ী Yang, Lin, Xia, Liangping, Wang, Yan, Hong, Shaodong, Chen, Haiyang, Liang, Shaobo, Peng, Peijian, Chen, Yong
প্রকাশিত PLoS One (2016)

Development and external validation of nomograms to predict the risk of skeletal metastasis at the time of diagnosis and skeletal metastasis-free survival in nasopharyngeal carcino...

অনুযায়ী Yang, Lin, Xia, Liangping, Wang, Yan, He, Shasha, Chen, Haiyang, Liang, Shaobo, Peng, Peijian, Hong, Shaodong, Chen, Yong
প্রকাশিত BMC Cancer (2017)

Nivolumab plus ipilimumab versus pembrolizumab as chemotherapy‐free, first‐line treatment for PD‐L1‐positive non‐small cell lung cancer

অনুযায়ী Zhou, Yixin, Zhang, Yaqiong, Guo, Guifang, Cai, Xiuyu, Yu, Hui, Cai, Yanyu, Zhang, Bei, Hong, Shaodong, Zhang, Li
প্রকাশিত Clin Transl Med (2020)

Multi-Targeted Antiangiogenic Tyrosine Kinase Inhibitors in Advanced Non-Small Cell Lung Cancer: Meta-Analyses of 20 Randomized Controlled Trials and Subgroup Analyses

অনুযায়ী Liang, Wenhua, Wu, Xuan, Hong, Shaodong, Zhang, Yaxiong, Kang, Shiyang, Fang, Wenfeng, Qin, Tao, Huang, Yan, Zhao, Hongyun, Zhang, Li
প্রকাশিত 2014

A multicenter, retrospective epidemiologic survey of the clinical features and management of bone metastatic disease in China

অনুযায়ী Yang, Yunpeng, Ma, Yuxiang, Sheng, Jin, Huang, Yan, Zhao, Yuanyuan, Fang, Wenfeng, Hong, Shaodong, Tian, Ying, Xue, Cong, Zhang, Li
প্রকাশিত Chin J Cancer (2016)

A novel prognostic score model incorporating CDGSH iron sulfur domain2 (CISD2) predicts risk of disease progression in laryngeal squamous cell carcinoma

অনুযায়ী Yang, Lin, Hong, Shaodong, Wang, Yan, He, Zhenyu, Liang, Shaobo, Chen, Haiyang, He, Shasha, Wu, Shu, Song, Libing, Chen, Yong
প্রকাশিত Oncotarget (2016)

Preferable background filtering for next-generation sequencing analysis in non-small cell lung cancer: pericarcinomatous tissues or peripheral blood lymphocytes?

অনুযায়ী Zhang, Yaxiong, Chang, Lianpeng, Fang, Wenfeng, Yang, Yunpeng, Zhang, Lanjun, Hong, Shaodong, Zhou, Huaqiang, Guan, Yanfang, Yi, Xin, Zhang, Li
প্রকাশিত Cancer Commun (Lond) (2019)

EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer

অনুযায়ী Fang, Wenfeng, Huang, Yihua, Hong, Shaodong, Zhang, Zhonghan, Wang, Minghui, Gan, Jiadi, Wang, Wenjing, Guo, Honglin, Wang, Kai, Zhang, Li
প্রকাশিত BMC Cancer (2019)

The ACTIVE study protocol: apatinib or placebo plus gefitinib as first-line treatment for patients with EGFR-mutant advanced non-small cell lung cancer (CTONG1706)

অনুযায়ী Zhang, Zhonghan, Luo, Fan, Zhang, Yang, Ma, Yuxiang, Hong, Shaodong, Yang, Yunpeng, Fang, Wenfeng, Huang, Yan, Zhang, Li, Zhao, Hongyun
প্রকাশিত Cancer Commun (Lond) (2019)

Patients with Exon 19 Deletion Were Associated with Longer Progression-Free Survival Compared to Those with L858R Mutation after First-Line EGFR-TKIs for Advanced Non-Small Cell Lu...

অনুযায়ী Zhang, Yaxiong, Sheng, Jin, Kang, Shiyang, Fang, Wenfeng, Yan, Yue, Hu, Zhihuang, Hong, Shaodong, Wu, Xuan, Qin, Tao, Liang, Wenhua, Zhang, Li
প্রকাশিত 2014

Trends in incidence and associated risk factors of suicide mortality in patients with non‐small cell lung cancer

অনুযায়ী Zhou, Huaqiang, Xian, Wei, Zhang, Yaxiong, Chen, Gang, Zhao, Shen, Chen, Xi, Zhang, Zhonghan, Shen, Jiayi, Hong, Shaodong, Huang, Yan, Zhang, Li
প্রকাশিত Cancer Med (2018)

Suicide among cancer patients: adolescents and young adult (AYA) versus all-age patients

অনুযায়ী Zhou, Huaqiang, Xian, Wei, Zhang, Yaxiong, Yang, Yunpeng, Fang, Wenfeng, Liu, Jiaqing, Shen, Jiayi, Zhang, Zhonghan, Hong, Shaodong, Huang, Yan, Zhang, Li
প্রকাশিত Ann Transl Med (2019)

Anti‐epidermal growth factor receptor monoclonal antibody plus palliative chemotherapy as a first‐line treatment for recurrent or metastatic nasopharyngeal carcinoma

অনুযায়ী Chen, Chen, Zhou, Yixin, Zhang, Xuanye, Fu, Sha, Lin, Zuan, Fang, Wenfeng, Yang, Yunpeng, Huang, Yan, Zhao, Hongyun, Hong, Shaodong, Zhang, Li
প্রকাশিত Cancer Med (2020)

KEYNOTE‐032: A Randomized Phase I Study of Pembrolizumab in Chinese Patients with Advanced Non‐Small Cell Lung Cancer

অনুযায়ী Ma, Yuxiang, Fang, Wenfeng, Zhang, Yang, Yang, Yunpeng, Hong, Shaodong, Zhao, Yuanyuan, Xie, Shuang, Ge, Jun, Zhou, HaoJin, Zhao, Hongyun, Zhang, Li
প্রকাশিত Oncologist (2020)